[Supportive care for malignant melanoma].
In the systemic therapy of malignant melanoma, many forms of chemotherapy, immunotherapy, polychemotherapy and immunopolychemotherapy are being use. When administering such forms of therapy, optimal supportive care is essential. Important aspects include control of nausea and vomiting, prophylaxis and treatment of bone marrow failure, reducing fatigue and being alert to cutaneous side effects. Specific recommendations for all of these dermato-oncologic problems are provided in detail.
Mohr
P
P
Elbeklinikum Buxtehude, Am Krankenhaus 1, 21614, Buxtehude, Deutschland. Peter.Mohr@elbekliniken.de
D000740:Anemia / Q000209:etiology / Q000628:therapy; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005221:Fatigue / Q000209:etiology / Q000628:therapy; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care; D010198:Pancytopenia / Q000209:etiology / Q000628:therapy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents